Reaction

Right Ventricular Enlargement reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 312 reports · 3 co-occurring drugs

As of the last recalculation, Right Ventricular Enlargement appears in 312 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is SELEXIPAG (PRR 85.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Selexipag3085.685.7
Macitentan4651.851.8
Riociguat1736.736.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.